These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39188145)

  • 1. An
    Viswanathan S; Sivaraj R; Vasanthi AHR; Subramanian K; Ramesh V
    J Recept Signal Transduct Res; 2024 Aug; ():1-9. PubMed ID: 39188145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking analysis of flavonoids with AChE and BACE-1.
    Viswanathan S; Arumugam T; Subramanian K; Sivaraj R; Ramesh V; Vasanthi AHR
    Bioinformation; 2024; 20(2):103-109. PubMed ID: 38497082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel brain penetrant GSK-3β inhibitors toward Alzheimer's disease therapy by virtual screening, molecular docking, dynamic simulation, and MMPBSA analysis.
    Dasgupta A; Kalidass K; Farisha S; Saha R; Ghosh S; Ampasala DR
    J Biomol Struct Dyn; 2024 Oct; ():1-27. PubMed ID: 39427335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease.
    Londhe SG; Walhekar V; Shenoy M; Kini SG; Scotti MT; Scotti L; Kumar D
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β).
    Goyal S; Singh M; Thirumal D; Sharma P; Mujwar S; Mishra KK; Singh TG; Singh R; Singh V; Singh T; Ahmad SF
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and dynamics simulations revealed the potential inhibitory activity of honey-iQfood ingredients against GSK-3β and CDK5 protein targets for brain health.
    Zakaria NH; Mohamed Tap F; Aljohani GF; Abdul Majid FA
    J Biomol Struct Dyn; 2024 Jan; ():1-20. PubMed ID: 38165434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
    Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
    J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles.
    Nwadiugwu M; Onwuekwe I; Ezeanolue E; Deng H
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
    Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ
    Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer's disease using computational approaches.
    Shukla R; Singh TR
    J Genet Eng Biotechnol; 2021 May; 19(1):61. PubMed ID: 33945025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer's Disease.
    Jia YR; Guo ZQ; Guo Q; Wang XC
    Curr Med Sci; 2023 Oct; 43(5):847-854. PubMed ID: 37721665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy.
    Sai Varshini M; Aishwarya Reddy R; Thaggikuppe Krishnamurthy P
    J Drug Target; 2024 Sep; 32(8):909-917. PubMed ID: 38838023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update.
    Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S
    Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
    Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
    Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β.
    Sai Varshini M; Reddy RA; Krishnamurthy PT; Selvaraj D
    Curr Comput Aided Drug Des; 2024; 20(6):998-1012. PubMed ID: 37921183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of glycogen synthase kinase-3β in Alzheimer's disease: a novel therapeutic target.
    Mandlik DS; Mandlik SK; S A
    Int J Neurosci; 2024 Jun; 134(6):603-619. PubMed ID: 36178363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Docking and Dynamics Simulation of Natural Phenolic Compounds with GSK-3β: A Putative Target to Combat Mortality in Patients with COVID-19.
    Khamverdi Z; Mohamadi Z; Taherkhani A
    Recent Adv Inflamm Allergy Drug Discov; 2022; 15(1):16-34. PubMed ID: 35253634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of natural compounds by virtual screening, molecular docking and dynamics studies and evaluation of their effects on tau level
    Uzunhisarcıklı E; Çelik İ; Yerer MB
    J Biomol Struct Dyn; 2024; 42(1):384-392. PubMed ID: 36946204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.